“Ocrelizumab-Induced Psoriasis in A Patient With Relapsing-Remitting Multiple Sclerosis”. European Journal of Medical and Health Sciences 5, no. 3 (May 2, 2023): 1–2. Accessed October 11, 2025. https://www.ej-med.org/index.php/ejmed/article/view/1697.